Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Wiernik

Showing results (41-50 of 573) with videos related to

Pageof 58
Sort By:
Seminars in Oncology|February 1, 1990
Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinomaS Wadler, P H Wiernik
Cancer Treatment Reports|December 1, 1977
Phase II study of azotomycin in sarcomasP Chang, P H Wiernik
American Journal of Human Genetics|October 16, 1999
Pseudoautosomal linkage of Hodgkin diseaseM Horwitz, P H Wiernik
American Journal of Hematology|July 1, 1996
Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD)L Hui, P H Wiernik
Seminars in Oncology|September 1, 1981
Chemotherapy in the treatment of malignant mesotheliomaJ Aisner, P H Wiernik
Cancer Research|February 1, 1988
Partial reversal of doxorubicin resistance by forskolin and 1,9-dideoxyforskolin in murine sarcoma S180 variantsS Wadler, P H Wiernik
Nowotwory|January 1, 1978
[Chemotherapy in recurrent and inoperable breast neoplasms]J Aisner, P H Wiernik
Seminars in Oncology|September 1, 1981
Asbestos-related neoplasms. IntroductionJ Aisner, P H Wiernik
Cancer|December 15, 1980
Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lungJ Aisner, P H Wiernik
The Mount Sinai Journal of Medicine, New York|December 1, 1986
Malignant lymphomas, AIDS, and the pathogenic role of Epstein-Barr virusN Ciobanu, P H Wiernik
Pageof 58

Showing results (41-50 of 573) with videos related to

Sort By:
Pageof 58
Seminars in Oncology|February 1, 1990
Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinomaS Wadler, P H Wiernik
Cancer Treatment Reports|December 1, 1977
Phase II study of azotomycin in sarcomasP Chang, P H Wiernik
American Journal of Human Genetics|October 16, 1999
Pseudoautosomal linkage of Hodgkin diseaseM Horwitz, P H Wiernik
American Journal of Hematology|July 1, 1996
Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD)L Hui, P H Wiernik
Seminars in Oncology|September 1, 1981
Chemotherapy in the treatment of malignant mesotheliomaJ Aisner, P H Wiernik
Cancer Research|February 1, 1988
Partial reversal of doxorubicin resistance by forskolin and 1,9-dideoxyforskolin in murine sarcoma S180 variantsS Wadler, P H Wiernik
Nowotwory|January 1, 1978
[Chemotherapy in recurrent and inoperable breast neoplasms]J Aisner, P H Wiernik
Seminars in Oncology|September 1, 1981
Asbestos-related neoplasms. IntroductionJ Aisner, P H Wiernik
Cancer|December 15, 1980
Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lungJ Aisner, P H Wiernik
The Mount Sinai Journal of Medicine, New York|December 1, 1986
Malignant lymphomas, AIDS, and the pathogenic role of Epstein-Barr virusN Ciobanu, P H Wiernik
Pageof 58